Protein biomarkers in USWS for the detection of OSSC20
Candidate biomarkers | Techniques | Clinical significance | References |
---|---|---|---|
Interleukin (IL)-6, IL-8, IL-1α, IL-1β, TNF-α, tissue polypeptide antigen (TPA), Cyfra 21-1, cancer antigen 125 (CA 125), telomerase, Mac-2 binding protein (M2BP) | ELISA | Proinflammatory and proangiogenic cytokines found to be indicators of carcinogenic transformation from oral precancerous lesions to oral cancer. |
Katakura et al. 28 |
CD44, CD59, Profilin, MRP14 | Immunoblot | CD44 and CD59 are the very high sensitive cancer and benign diseases differentiate markers. |
Hu et al. 25 |
Glutathione | HPLC | Epidemiological marker for chemoprevention identifies the risk of development of OSCC. | Almadori et al. 26 |
Mac-2 binding protein (M2BP), Squamous cell carcinoma antigen 2, involucrin, calcyclin, cathepsin-G, azurocidin, transaldolase, carbonic anhydrase I, calgizzarin, myeloblastin, vitamin D-binding protein | ELISA, shotgun proteomics | M2BP is for detection of OSCC this biomarker gives a sensitivity of 90% and a specificity of 83%, and all of them serve as a clinical tool for the noninvasive diagnosis of OSCC. | Hu et al. 25 |
Immunoglobulin heavy chain constant region gamma (IgG), S100 calciumbinding protein, cofilin-1, transferrin, fibrin | LC/MS | IgG known to be an inhibitor of apoptosis, S100A2, an 11.4 kDa protein that is a prognostic biomarker for OSCC, cofilin proteins are involved in cancer progression, metastasis, and angiogenesis. Transferrin levels in saliva are associated with the size and stage of cancer. Fibrin in OSCC is involved in several carcinogenic processes. | Jou et al. 27 |
α-1-antitrypsin (AAT) | 2DE | AAT is useful for the prediction and determining the aggression of OSCC. | Righini et al. 34 |
Secretory leukocyte peptidase inhibitor (SLPI), cystatin A, keratin 36, thioredoxin, haptoglobin (HAP), salivary zinc finger, protein 510 peptide, a-amylase, and albumin | MS-based proteomics | SLPI, cystatin A, keratin 36 are potentially involved in the preventive treatment of OSCC. Thioredoxin mRNA levels are elevated in oral cancers and in other cancers as well. Salivary zinc finger, protein 510 peptide, a-amylase, and albumin are useful in the early detection of OSCC. | Reddy et al. 35 |